Management of cardiogenic shock complicating myocardial
infarction: an update 2019

J 2019

Management of cardiogenic shock complicating myocardial infarction: an update 2019

THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER, S. DESCH et. al.

Basic information

Original name

Management of cardiogenic shock complicating myocardial infarction: an update 2019

Authors

THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER and S. DESCH

Edition

European heart journal, Oxford, Oxford University Press, 2019, 0195-668X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

DAPT-SHOCK AMI

Impact factor

Impact factor: 22.673

RIV identification code

RIV/00216224:14110/19:00123181

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1093/eurheartj/ehz363

UT WoS

000490152600009

Keywords (in Czech)

DAPT-SHOCK AMI; Shock; Heart failure; Treatment; Percutaneous coronary intervention; Myocardial infarction; Assist device

Keywords in English

DAPT-SHOCK AMI; Shock; Heart failure; Treatment; Percutaneous coronary intervention; Myocardial infarction; Assist device

Abstract

V originále

Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial (ClinicalTrials.gov: NCT03551964). Cardiogenic shock (CS) remains the most common cause of death in patients admitted with acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of 40-50% during the last two decades. Early revascularization, vasopressors and inotropes, fluids, mechanical circulatory support, and general intensive care measures are widely used for CS management. However, there is only limited evidence for any of the above treatment strategies except for revascularization and the relative ineffectiveness of intra-aortic balloon pumping. This updated review will outline the management of CS complicating AMI with major focus on state-of-the art treatment.

Links

90090, large research infrastructures

Name: CZECRIN II

Citovat

THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER and S. DESCH. Management of cardiogenic shock complicating myocardial infarction: an update 2019. European heart journal. Oxford: Oxford University Press, 2019, vol. 40, No 32, p. "2671"-"+", 15 pp. ISSN 0195-668X. Available from: https://dx.doi.org/10.1093/eurheartj/ehz363.

@article{1808359,
   author = {Thiele, H. and Ohman, E. M. and deWahaandThiele, S. and Zeymer, U. and Desch, S.},
   article_location = {Oxford},
   article_number = {32},
   doi = {http://dx.doi.org/10.1093/eurheartj/ehz363},
   keywords = {DAPT-SHOCK AMI; Shock; Heart failure; Treatment; Percutaneous coronary intervention; Myocardial infarction; Assist device},
   language = {eng},
   issn = {0195-668X},
   journal = {European heart journal},
   note = {DAPT SHOCK AMI (Prague-23)},
   title = {Management of cardiogenic shock complicating myocardial infarction: an update 2019},
   url = {https://academic.oup.com/eurheartj/article/40/32/2671/5528526},
   volume = {40},
   year = {2019}
}

TY  - JOUR
ID  - 1808359
AU  - Thiele, H. - Ohman, E. M. - deWaha-Thiele, S. - Zeymer, U. - Desch, S.
PY  - 2019
TI  - Management of cardiogenic shock complicating myocardial infarction: an update 2019
JF  - European heart journal
VL  - 40
IS  - 32
SP  - "2671"-"+"
EP  - "2671"-"+"
PB  - Oxford University Press
SN  - 0195668X
N1  - DAPT SHOCK AMI (Prague-23)
KW  - DAPT-SHOCK AMI
KW  - Shock
KW  - Heart failure
KW  - Treatment
KW  - Percutaneous coronary intervention
KW  - Myocardial infarction
KW  - Assist device
UR  - https://academic.oup.com/eurheartj/article/40/32/2671/5528526
N2  - Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial (ClinicalTrials.gov: NCT03551964). Cardiogenic shock (CS) remains the most common cause of death in patients admitted with acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of 40-50% during the last two decades. Early revascularization, vasopressors and inotropes, fluids, mechanical circulatory support, and general intensive care measures are widely used for CS management. However, there is only limited evidence for any of the above treatment strategies except for revascularization and the relative ineffectiveness of intra-aortic balloon pumping. This updated review will outline the management of CS complicating AMI with major focus on state-of-the art treatment.
ER  -

THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER and S. DESCH. Management of cardiogenic shock complicating myocardial infarction: an update 2019. \textit{European heart journal}. Oxford: Oxford University Press, 2019, vol.~40, No~32, p.~''2671''-''+'', 15 pp. ISSN~0195-668X. Available from: https://dx.doi.org/10.1093/eurheartj/ehz363.

Detailed Information on Publication Record